COVID-19 treatment | Indian companies begin exports of Favipiravir, but wait for approval in India
Sources told Moneycontrol that Glenmark's Favipiravir is expected to get approval from drug regulator any moment, based on the intermediate data from the clinical trials given the urgency of the situation